TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design

• URL: http://arxiv.org/abs/2310.03223v6
• Date: Fri, 6 Sep 2024 17:26:00 GMT
• Title: TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design
• Authors: Tony Shen, Seonghwan Seo, Grayson Lee, Mohit Pandey, Jason R Smith, Artem Cherkasov, Woo Youn Kim, Martin Ester,
• Abstract summary: TacoGFN is a novel GFlowNet-based approach for structure-based drug design. It can generate molecules conditioned on any protein pocket structure with probabilities proportional to its affinity and property rewards. In the generative setting for CrossDocked 2020 benchmark, TacoGFN attains a state-of-the-art success rate of $56.0%$ and $-8.44$ kcal/mol in median Vina Dock score.
• Score: 3.45184803671951
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Searching the vast chemical space for drug-like molecules that bind with a protein pocket is a challenging task in drug discovery. Recently, structure-based generative models have been introduced which promise to be more efficient by learning to generate molecules for any given protein structure. However, since they learn the distribution of a limited protein-ligand complex dataset, structure-based methods do not yet outperform optimization-based methods that generate binding molecules for just one pocket. To overcome limitations on data while leveraging learning across protein targets, we choose to model the reward distribution conditioned on pocket structure, instead of the training data distribution. We design TacoGFN, a novel GFlowNet-based approach for structure-based drug design, which can generate molecules conditioned on any protein pocket structure with probabilities proportional to its affinity and property rewards. In the generative setting for CrossDocked2020 benchmark, TacoGFN attains a state-of-the-art success rate of $56.0\%$ and $-8.44$ kcal/mol in median Vina Dock score while improving the generation time by multiple orders of magnitude. Fine-tuning TacoGFN further improves the median Vina Dock score to $-10.93$ kcal/mol and the success rate to $88.8\%$, outperforming all optimization-based methods.

Related papers

• GFlowNet Pretraining with Inexpensive Rewards [2.924067540644439]
  We introduce Atomic GFlowNets (A-GFNs), a foundational generative model leveraging individual atoms as building blocks to explore drug-like chemical space more comprehensively. We propose an unsupervised pre-training approach using offline drug-like molecule datasets, which conditions A-GFNs on inexpensive yet informative molecular descriptors. We further our method by implementing a goal-conditioned fine-tuning process, which adapts A-GFNs to optimize for specific target properties.
  arXiv  Detail & Related papers  (2024-09-15T11:42:17Z)
• Decomposed Direct Preference Optimization for Structure-Based Drug Design [47.561983733291804]
  We propose DecompDPO, a structure-based optimization method to align diffusion models with pharmaceutical needs. DecompDPO can be effectively used for two main purposes: fine-tuning pretrained diffusion models for molecule generation across various protein families, and molecular optimization given a specific protein subpocket after generation.
  arXiv  Detail & Related papers  (2024-07-19T02:12:25Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• Geometric-informed GFlowNets for Structure-Based Drug Design [4.8722087770556906]
  We employ Generative Flow Networks (GFlowNets) to explore the vast space of drug-like molecules. We introduce a novel modification to the GFlowNet framework by incorporating trigonometrically consistent embeddings. Experiments conducted using CrossDocked 2020 demonstrated an improvement in the binding affinity between generated molecules and protein pockets.
  arXiv  Detail & Related papers  (2024-06-16T09:32:19Z)
• PILOT: Equivariant diffusion for pocket conditioned de novo ligand generation with multi-objective guidance via importance sampling [8.619610909783441]
  We propose an in-silico approach for the $textitde novo$ generation of 3D ligand structures using the equivariant diffusion model PILOT. Its multi-objective-based importance sampling strategy is designed to direct the model towards molecules that exhibit desired characteristics. We employ PILOT to generate novel metrics for unseen protein pockets from the Kinodata-3D dataset.
  arXiv  Detail & Related papers  (2024-05-23T17:58:28Z)
• DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization [49.85944390503957]
  DecompOpt is a structure-based molecular optimization method based on a controllable and diffusion model. We show that DecompOpt can efficiently generate molecules with improved properties than strong de novo baselines.
  arXiv  Detail & Related papers  (2024-03-07T02:53:40Z)
• SE(3)-Stochastic Flow Matching for Protein Backbone Generation [54.951832422425454]
  We introduce FoldFlow, a series of novel generative models of increasing modeling power based on the flow-matching paradigm over $3mathrmD$ rigid motions. Our family of FoldFlowgenerative models offers several advantages over previous approaches to the generative modeling of proteins.
  arXiv  Detail & Related papers  (2023-10-03T19:24:24Z)
• Balancing Exploration and Exploitation: Disentangled $\beta$-CVAE in De Novo Drug Design [0.0]
  We propose a molecular-graph $beta$-CVAE model for de novo drug design. We optimised the octanol-water partition coefficient (ClogP), molar refractivity (CMR), quantitative estimate of drug-likeness (QED), and synthetic accessibility score (SAS) Our model generated an average of 30.07% $pm$ 0.01% molecules for both desired properties.
  arXiv  Detail & Related papers  (2023-06-02T16:58:15Z)
• Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model [4.815696666006742]
  Structure-based de novo method can overcome the data scarcity of active by incorporating drug-target interaction into deep generative architectures. Here, we demonstrate a widely used and fast protein sequence-based reinforcement learning model for drug discovery. As a proof of concept, the RL model was utilized to design molecules for four targets.
  arXiv  Detail & Related papers  (2022-08-14T10:41:52Z)
• MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
  generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
  arXiv  Detail & Related papers  (2020-10-05T20:18:42Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.